NCT03775187Available不适用
Expanded Access to Burosumab
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- Available
研究概览
简要总结
Individual patient expanded access requests may be considered for patients who have no other treatment options
详细描述
Expanded access may be available outside of the US in countries prior to approval by the local regulatory agencies. For full details, please visit the links provided below.
研究设计
- 研究类型
- Expanded Access
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
Available
不适用
Expanded Access to MepseviiMPS VIIMucopolysaccharidosis VIISly SyndromeNCT03775174Ultragenyx Pharmaceutical Inc
Available
不适用
Expanded Access to Velmanase AlfaAlpha-MannosidosisNCT04959240Chiesi Farmaceutici S.p.A.
Unknown
不适用
Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular System InjuriesVascular System InjuriesNCT03631056Humacyte, Inc.
Available
不适用
Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene AutoleucelMantle Cell LymphomaAcute Lymphoblastic LeukemiaNCT05776134Kite, A Gilead Company
Available
不适用
Expanded Access to TriheptanoinLong Chain Fatty Acid Oxidation DisordersNCT03773770Ultragenyx Pharmaceutical Inc